Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zarmina Durrani is active.

Publication


Featured researches published by Zarmina Durrani.


Fems Immunology and Medical Microbiology | 2003

Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens

Jacqueline I. Keenan; Sjoerd Rijpkema; Zarmina Durrani; Justin A. Roake

Mice and guinea pigs were intranasally immunized with either recombinant lipoprotein 20 or Helicobacter pylori outer membrane vesicles (OMV). Cholera toxin was used as mucosal adjuvant. In mice, both vaccines elicited systemic and local IgG responses, which correlated with significantly lower levels of H. pylori colonization. In contrast, only OMV proved immunogenic in guinea pigs, with the development of both systemic and local immune responses. These antibodies did not, however, correlate with protection in these animals, which suggests that vaccine formulation is as important as choice of antigen in the development of an H. pylori vaccine.


Fems Immunology and Medical Microbiology | 2003

Investigation of the biological relevance of Helicobacter pylori cagE locus diversity, presence of CagA tyrosine phosphorylation motifs and vacuolating cytotoxin genotype on IL-8 induction in gastric epithelial cells

Robert J. Owen; Sally Sharp; Andrew J. Lawson; Zarmina Durrani; Sjoerd Rijpkema; Mark Kidd

Isolates of Helicobacter pylori from dyspeptic patients in England and South Africa were tested for ability to induce interleukin-8 (IL-8) in gastric cells. All isolates were cagA-positive, which was used as a marker for the presence of the cag pathogenicity island. The aims were to determine if activities were related to diversity within cagE (HP0544), a locus encoding a key component in the Type IV secretion system, and if disease severity might be linked to a combination of strain features. We found that isolates were heterogeneous in ability to induce IL-8 activity with the 23 positive isolates (59%) showing activities ranging from 260 to 3200 pg ml(-1). The cagE locus was detected in most isolates and RFLP analysis of a 1.52-kb internal fragment showed interstrain diversity with 12 combined (MboI/NlaIII) types. Most cagE genotypes were not associated with IL-8 induction, however two genotypes were found only in IL-8-inducing strains and one genotype was associated with lack of IL-8 induction. IL-8 activity was not associated with either the number or composition of cagA tyrosine phosphorylation motifs and vacA m-type. Although we found a weak association between cagE type and the ability to induce IL-8, our results imply that gastric cell factors or bacterial factors other than vacA, cagA and cagE are involved in the induction of IL-8 and the development of severe gastric disease.


Fems Immunology and Medical Microbiology | 2003

Orogastric vaccination of guinea pigs with Helicobacter pylori sonicate and a high dose of cholera toxin lowers the burden of infection

Zarmina Durrani; Sjoerd Rijpkema

Guinea pigs were vaccinated orogastrically with Helicobacter pylori cell sonicate (CS) and 10 microg or 100 microg cholera toxin (CT) or CT only. Nai;ve animals were used as a control. In both experiments, vaccination primed the local IgG and IgA response, irrespective of the CT dose. After challenge, only the group of animals immunised with CS and 100 microg CT had a significantly lower number of H. pylori in the antral region of the stomach, but vaccination did not prevent H. pylori infection. This protective effect was not associated with a switch in IgG subclass, which remained predominantly IgG2. The levels of specific antibodies in serum and the gastric mucosa which were similar to naive unprotected animals. In conclusion, the ability of mucosal adjuvants such as CT to induce a protective immune response may be host dependent and findings in the Helicobacter-mouse model should be interpreted with caution.


The Open Vaccine Journal | 2008

A Study of PA DNA/Dendron Nanoparticles for Genetic Immunisation Against Anthrax

Suzie Ribeiro; Sjoerd Rijpkema; Zarmina Durrani; Alexander T. Florence

Protective antigen (PA), the binding subunit of toxins produced by Bacillus anthracis is singularly the most important antigen required for specific immunity to anthrax disease. We used cationic poly-lysine dendrons to develop a genetic anthrax vaccine. Plasmid CMV/ER PA83 which encoded full length PA 83 was complexed with dendrons to form dendriplexes. Two types of dendron were used: C0 and C18.These were mixed with DNA to form dendriplexes, of ap- proximately 80 nm in size, which were tested for immunogenicity. A/J and BALB/c mice were vaccinated with dendri- plexes containing 1� g and 50 � g plasmid DNA per dose over a period of 6 weeks. Immunisation with naked PA DNA did not induce an antibody response even after secondary boosting, whereas both dendriplexes produced strong anti-PA anti- body response. This response was dose dependent. We conclude that dendriplexes show superior immunogenicity com- pared to naked PA DNA in both mouse strains and that C18 dendriplexes with 50 �g plasmid DNA are most efficacious. However, the elicited antibodies did not neutralise lethal toxin in vitro. Therefore further work is required to improve these preparations in order to elicit functional antibodies.


Vaccine | 2007

Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen

Le H. Duc; Huynh A. Hong; Helen S. Atkins; Helen Flick-Smith; Zarmina Durrani; Sjoerd Rijpkema; Richard W. Titball; Simon M. Cutting


Journal of Medical Microbiology | 2004

Role of the Helicobacter pylori outer-membrane proteins AlpA and AlpB in colonization of the guinea pig stomach

Ramon De Jonge; Zarmina Durrani; Sjoerd Rijpkema; Ernst J. Kuipers; Arnoud H. M. Van Vliet; Johannes G. Kusters


Biologicals | 1999

Non-pertussis Components of Combination Vaccines: Problems with Potency Testing

Dorothea Sesardic; C.S. Dawes; Kay McLellan; Zarmina Durrani; Susan E. Yost; Michael J. Corbel


Fems Immunology and Medical Microbiology | 2001

Analysis of host responses of guinea pigs during Helicobacter pylori infection

Sjoerd Rijpkema; Zarmina Durrani; Gary Beavan; Janet R. Gibson; Jane Luck; Robert J. Owen; Ghazi Auda


Journal of Medical Microbiology | 2004

Assessing clonality of Vibrio cholerae Inaba isolates by characterization of nonsense mutations in wbeT

Sjoerd Rijpkema; Zarmina Durrani; T. Ramamurthy; G. Balakrish Nair


Biologicals | 2004

Detection of O-acetylated Vi polysaccharide of Salmonella enterica subspecies typhi by Enzyme Immunoassay

Sjoerd Rijpkema; Zarmina Durrani; Xavier Lemercinier; Christopher Jones

Collaboration


Dive into the Zarmina Durrani's collaboration.

Top Co-Authors

Avatar

Sjoerd Rijpkema

National Institute for Biological Standards and Control

View shared research outputs
Top Co-Authors

Avatar

Robert J. Owen

Public health laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arnoud H. M. Van Vliet

National Institute for Biological Standards and Control

View shared research outputs
Top Co-Authors

Avatar

C.S. Dawes

National Institute for Biological Standards and Control

View shared research outputs
Top Co-Authors

Avatar

Christopher Jones

National Institute for Biological Standards and Control

View shared research outputs
Top Co-Authors

Avatar

Dorothea Sesardic

National Institute for Biological Standards and Control

View shared research outputs
Researchain Logo
Decentralizing Knowledge